Trial Profile

A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 05 Dec 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rose bengal sodium (Primary)
Indications Plaque psoriasis
Focus Therapeutic Use
Sponsors Provectus Biopharmaceuticals

Most Recent Events

30 Nov 2017 According to a Provectus Biopharmaceuticals media release, results were presented at the 8th International Congress of Psoriasis : from gene to clinic (Psoriasis G2C).
08 Nov 2017 Status changed from active, no longer recruiting to completed.
16 Sep 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com